Ariane Clerveau Beauboeuf
Family Medicine · North Miami Beach, FLNPI 1538639257
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 226 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,228, more than ten times the $22 reported in 2019.
Across 226 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$791
- Lilly USA, LLC$523
- Pfizer$518
- AstraZeneca$485
- AbbVie$380
- Novo Nordisk$327
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,844100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 30 | $791 |
| Lilly USA, LLC | 29 | $523 |
| Pfizer | 23 | $518 |
| AstraZeneca | 24 | $485 |
| AbbVie | 20 | $380 |
| Novo Nordisk | 12 | $327 |
| GSK | 10 | $281 |
| Shield Therapeutics Inc | 6 | $189 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $173 |
| Sanofi-aventis U.S. LLC | 8 | $161 |
| Johnson & Johnson | 8 | $151 |
| Exact Sciences | 5 | $113 |
| Redhill Biopharma Inc. | 4 | $84 |
| Abbott | 4 | $81 |
| Radius Health, Inc. | 4 | $71 |
| Phadia US Inc. | 4 | $64 |
| Sumitomo Pharma America, Inc. | 2 | $53 |
| Boehringer Ingelheim | 2 | $52 |
| Idorsia Pharmaceuticals US Inc | 2 | $48 |
| Kowa Pharmaceuticals America, Inc. | 3 | $42 |
| Gilead | 2 | $39 |
| Amgen(2 entities) | 2 | $33 |
| Merck | 2 | $31 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $22 |
| IBSA Pharma Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $22 |
| Novartis | 1 | $18 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$125
- Kerendia$117
- TRELEGY ELLIPTA$117
How this compares
$4,844 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 35 | $36,443 |
| JardianceEmpagliflozin | 28 | $31,833 |
| OzempicSemaglutide | 18 | $16,905 |
| LinzessLinaclotide | 11 | $11,095 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $4,102 |
| Novolog FlexpenInsulin Aspart | 14 | $1,843 |
| Nifedipine ErNifedipine | 56 | $1,317 |
| Atorvastatin Calcium | 142 | $1,251 |
| Glipizide | 65 | $1,125 |
| Losartan Potassium | 77 | $892 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $874 |
| Rosuvastatin Calcium | 80 | $686 |
| Metformin Hcl | 122 | $616 |
| Simvastatin | 47 | $443 |
| Gabapentin | 70 | $431 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $485 | $36,44335 claims |
| Boehringer IngelheimJardiance | $52 | $31,83328 claims |
| Novo NordiskOzempic | $327 | $16,90518 claims |
| AbbVieLinzess | $380 | $11,09511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in North Miami Beach
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.